Leiden University Medical Center or LUMC is the university hospital affiliated with Leiden University, of which it forms the medical faculty. It is located in Leiden, Netherlands. LUMC is a modern university medical center for research, education and patient care.

During the past decade, Leiden University Medical Center conducted 287 clinical trials. In the 10-year time frame, 287 clinical trials started and 45 clinical trials were completed, i.e. on average, 15.7% percent of trials that started reached the finish line to date. In the past 5 years, 142 clinical trials started and 28 clinical trials were completed. i.e. 19.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Leiden University Medical Center" #1 sponsor was "Leiden University Medical Center" with 142 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 69 trials sponsored, "Radboud University Medical Center" with 18 trials sponsored, "Erasmus Medical Center" with 10 trials sponsored and "University Medical Center Groningen" with 10 trials sponsored. Other sponsors include 223 different institutions and companies that sponsored additional 141 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Leiden University Medical Center" #1 collaborator was "Leiden University Medical Center" with 52 trials as a collaborator, "Erasmus Medical Center" with 27 trials as a collaborator, "ZonMw: The Netherlands Organisation for Health Research and Development" with 20 trials as a collaborator, "Dutch Cancer Society" with 15 trials as a collaborator and "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 14 trials as a collaborator. Other collaborators include 625 different institutions and companies that were collaborators in the rest 445 trials.

According to Clinical.Site data, the most researched conditions in "Leiden University Medical Center" are "Leukemia" (15 trials), "Breast Cancer" (11 trials), "Sarcoma" (11 trials), "Heart Failure" (10 trials) and "Lymphoma" (10 trials). Many other conditions were trialed in "Leiden University Medical Center" in a lesser frequency.

Most popular intervention types in "Leiden University Medical Center" are "Drug" (257 trials), "Other" (79 trials), "Procedure" (70 trials), "Biological" (65 trials) and "Device" (56 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (48 trials), "radiation therapy" (18 trials), "cyclophosphamide" (15 trials), "cisplatin" (14 trials) and "doxorubicin hydrochloride" (13 trials). Other intervention names were less common.

The vast majority of trials in "Leiden University Medical Center" are 402 trials for "All" genders, 53 trials for "Female" genders and 21 trials for "Male" genders.

Currently, there are 141 active trials in "Leiden University Medical Center". 6 are not yet recruiting, 109 are recruiting, 23 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 217 completed trials in Leiden University Medical Center, undefined suspended trials, and 38 terminated clinical trials to date.

Out of the total trials that were conducted in Leiden University Medical Center, 38 "Phase 1" clinical trials were conducted, 122 "Phase 2" clinical trials and 132 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 41 trials, and there were also 94 trials that are defined as “Not Applicable".